Zimmer Biomet Holdings Inc (ZBH) - Total Liabilities
Based on the latest financial reports, Zimmer Biomet Holdings Inc (ZBH) has total liabilities worth $10.72 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ZBH shareholders equity momentum to track the company's year-over-year net asset growth rate.
Zimmer Biomet Holdings Inc - Total Liabilities Trend (1999–2024)
This chart illustrates how Zimmer Biomet Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See ZBH free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Zimmer Biomet Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Zimmer Biomet Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Krung Thai Bank Public Company Limited
BK:KTB
|
Thailand | ฿3.45 Trillion |
|
JSC National Atomic Company Kazatomprom
IL:KAP
|
UK | $1.24 Trillion |
|
Solar Industries India Limited
NSE:SOLARINDS
|
India | Rs43.70 Billion |
|
WOLTERS KLUWER ADR EO-12
F:WOS
|
Germany | €8.79 Billion |
|
Genmab A/S
CO:GMAB
|
Denmark | Dkr1.27 Billion |
|
Suncorp Group Ltd
AU:SUNPH
|
Australia | AU$19.54 Billion |
|
PTT Exploration and Production Public Company Limited
BK:PTTEP
|
Thailand | ฿455.09 Billion |
|
Hanwha Ocean Co., Ltd
KO:042660
|
Korea | ₩13.06 Trillion |
Liability Composition Analysis (1999–2024)
This chart breaks down Zimmer Biomet Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zimmer Biomet Holdings Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zimmer Biomet Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zimmer Biomet Holdings Inc (1999–2024)
The table below shows the annual total liabilities of Zimmer Biomet Holdings Inc from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $8.89 Billion | -1.33% |
| 2023-12-31 | $9.01 Billion | -0.33% |
| 2022-12-31 | $9.04 Billion | -16.23% |
| 2021-12-31 | $10.79 Billion | -11.69% |
| 2020-12-31 | $12.22 Billion | -0.23% |
| 2019-12-31 | $12.25 Billion | -4.71% |
| 2018-12-31 | $12.85 Billion | -10.00% |
| 2017-12-31 | $14.28 Billion | -16.08% |
| 2016-12-31 | $17.01 Billion | -3.30% |
| 2015-12-31 | $17.59 Billion | +465.37% |
| 2014-12-31 | $3.11 Billion | -5.13% |
| 2013-12-31 | $3.28 Billion | +4.27% |
| 2012-12-31 | $3.15 Billion | +4.85% |
| 2011-12-31 | $3.00 Billion | +34.64% |
| 2010-12-31 | $2.23 Billion | +3.81% |
| 2009-12-31 | $2.15 Billion | +35.44% |
| 2008-12-31 | $1.59 Billion | +34.18% |
| 2007-12-31 | $1.18 Billion | +12.38% |
| 2006-12-31 | $1.05 Billion | +1.39% |
| 2005-12-31 | $1.04 Billion | -40.62% |
| 2004-12-31 | $1.75 Billion | -12.95% |
| 2003-12-31 | $2.01 Billion | +307.17% |
| 2002-12-31 | $492.60 Million | -26.07% |
| 2001-12-31 | $666.30 Million | +98.07% |
| 2000-12-31 | $336.40 Million | +56.47% |
| 1999-12-31 | $215.00 Million | -- |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more